Virax Biolabs Group Ltd - Ordinary Shares (VRAX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
VRAX on Nasdaq
Shares outstanding
4,440,602
Price per share
$0.34
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
94,809
Total reported value
$57,043
% of total 13F portfolios
0%
Share change
+59,654
Value change
+$29,376
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Virax Biolabs Group Ltd - Ordinary Shares (VRAX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Foster James Alexander Cunliffe 8.3% +14% $232,199 +$30,634 368,570 +15% James Foster 31 Mar 2025

As of 30 Sep 2025, 4 institutional investors reported holding 94,809 shares of Virax Biolabs Group Ltd - Ordinary Shares (VRAX). This represents 2.1% of the company’s total 4,440,602 outstanding shares.

Institutional Holders of Virax Biolabs Group Ltd - Ordinary Shares (VRAX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 7,492 $2,592 +$1,430 $0.35 1
2025 Q3 94,809 $57,043 +$29,376 $0.60 4
2025 Q2 35,155 $28,617 -$38,558 $0.80 2
2025 Q1 63,098 $71,534 -$27,747 $1.14 4
2024 Q4 63,007 $141,366 -$294,712 $2.25 7
2024 Q3 218,370 $423,638 +$328,879 $1.94 5
2024 Q2 70,777 $81,774 +$68,070 $1.16 7
2024 Q1 17,460 $12,519 -$182,221 $0.72 3
2023 Q4 133,508 $195,382 +$195,382 $1.46 4